178 related articles for article (PubMed ID: 8112645)
1. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
3. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
7. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
8. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
9. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
Xue F; Jiao S; Zhao F
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
Takahashi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell cycle in patients with stage I endometrial carcinoma.
Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
[TBL] [Abstract][Full Text] [Related]
15. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of DNA ploidy in endometrial cancer.
Ikeda M; Watanabe Y; Nanjoh T; Noda K
Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160
[TBL] [Abstract][Full Text] [Related]
17. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
19. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
20. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
Bell JG; Minnick A; Reid GC; Judis J; Brownell M
Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
